<code id='F399A421F8'></code><style id='F399A421F8'></style>
    • <acronym id='F399A421F8'></acronym>
      <center id='F399A421F8'><center id='F399A421F8'><tfoot id='F399A421F8'></tfoot></center><abbr id='F399A421F8'><dir id='F399A421F8'><tfoot id='F399A421F8'></tfoot><noframes id='F399A421F8'>

    • <optgroup id='F399A421F8'><strike id='F399A421F8'><sup id='F399A421F8'></sup></strike><code id='F399A421F8'></code></optgroup>
        1. <b id='F399A421F8'><label id='F399A421F8'><select id='F399A421F8'><dt id='F399A421F8'><span id='F399A421F8'></span></dt></select></label></b><u id='F399A421F8'></u>
          <i id='F399A421F8'><strike id='F399A421F8'><tt id='F399A421F8'><pre id='F399A421F8'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          Wikipedia

          author:leisure time    - browse:5
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus